The in vitro potentials of the compounds especially compound XII to treat AD (in terms of AChE and BChE inhibition), diabetes (in terms of α-amylase and α-glucosidase inhibition), and oxidative stress (in terms of free radical scavenging) is highly encouraging as the three activities in the same agent is direly needed. The gene discussed is ACHE; the disease is diabetes mellitus.